SciFluor Life Sciences , LLC

SciFluor Life Sciences, LLC

SciFluor Life Sciences is an early-stage drug discovery company, engaged in developing small-molecule therapeutics for the treatment of various diseases including ophthalmology, fibrosis and neurology.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://scifluor.com
Disease Focus
STOCK CODENon Listed
Address
An Allied Minds Company300 Technology Square, Suite 201, MA 02139
Cambridge
United States
Email
Contact Number
+1 617-684-4748

SciFluor Life Sciences is an early-stage drug discovery company, engaged in developing small-molecule therapeutics for the treatment of various diseases including ophthalmology, fibrosis and neurology.

Allied Minds, a Boston private equity firm focused on building companies, launched SciFluor Life Sciences LLC as well as invested $5 million in the company to support the company. SciFluor is presently developing SF0166,a selective small molecule inhibitor of integrin ?v?3 for the treatment of Age-related macular degeneration (AMD). It is presently in phase 1/2 clinical trial with patients of Diabetic Macular Edema (DME) (NCT02914613).

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/scifluor-life-sciences-llc” connections=”true” suffix=””]